N-Terminal Rather Than Full-Length Osteopontin or Its C-Terminal Fragment Is Associated With Carotid-Plaque Inflammation in Hypertensive Patients
Open Access
- 7 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 26 (3) , 326-333
Abstract
Hypertensive patients develop carotid atherosclerotic plaques with enhanced inflammation. Full-length osteopontin (OPN-FL), a multifunctional protein whose levels are elevated in association with atherosclerosis, is cleaved by thrombin and matrix metalloproteinases to form a C-terminal and a putatively biologically active N-terminal fragment (OPN-C, OPN-N, respectively). We conducted a study to examine whether plaque inflammation in hypertensive patients corresponds to the expression of OPN or of its cleaved forms or both. We collected 42 carotid plaques from 41 consecutive hypertensive patients during carotid endarterectomy. Plaque tissue was used to measure matrix metalloproteinase-12 (MMP-12) and OPN proteins, and for the classification of plaques as showing low- or high-degree inflammation through histological and immunohistochemical evaluation. Fifteen highly inflamed plaques and 27 plaques with characteristics of low-grade inflammation were collected. Moderate to heavy staining for OPN characterized 87% of the plaques with high-degree inflammation but only 44% of those with low-degree inflammation, corresponding to the percentages of plaques that were heavily stained for the macrophage marker CD68 (93% versus 26%, respectively, P < 0.01). Western blot analysis showed that the abundance of OPN-FL and OPN-C was comparable in the two groups. However, the abundance of OPN-N was significantly greater in the highly inflamed plaques (median, 3.8 (range, 0.8–7.3) vs. median, 0.9 (range, 0.2–1.5); P = 0.017, respectively). The abundance of MMP-12 was significantly greater in the high- than in the low-degree plaque inflammation group (4.8 (range 1.9–8.8) vs. 1.1 (range 0.3–1.4), respectively; P = 0.03). The N-terminal fragment of osteopontin, rather than OPN-FL or OPN-C, is associated with carotid plaque inflammation in hypertensive patients. Future studies should assess whether targeting OPN cleavage could present a new approach to preventing high-risk carotid plaques.Keywords
This publication has 21 references indexed in Scilit:
- Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque InstabilityStroke, 2008
- Sonographic Carotid Plaque Morphologic Characteristics and Vascular Risk FactorsJournal of Ultrasound in Medicine, 2008
- The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerabilityJournal of Vascular Surgery, 2008
- Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid AtherosclerosisStroke, 2004
- 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertensionJournal Of Hypertension, 2003
- 2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*Journal Of Hypertension, 2003
- Alterations of Arterial Physiology in Osteopontin-Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Development of atherosclerosis in osteopontin transgenic miceHeart and Vessels, 2002
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- The Nature and Significance of OsteopontinConnective Tissue Research, 1989